(Q48168144)

9 February 2018

title

Glatiramer acetate-reactive T cells produce brain-derived neurotrophic factor (English)

1 reference

https://api.crossref.org/works/10.1016/S0022-510X(03)00177-1

23 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0022-510X(03)00177-1

23 March 2024

author name string

Man Chen

series ordinal

1

1 reference

9 February 2018

Reuben Mari Valenzuela

series ordinal

2

1 reference

9 February 2018

Suhayl Dhib-Jalbut

series ordinal

3

1 reference

9 February 2018

language of work or name

English

1 reference

National Center for Biotechnology Information

PubMed ID

14568126

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14568126

23 March 2024

publication date

1 November 2003

1 reference

9 February 2018

15 November 2003

1 reference

National Center for Biotechnology Information

PubMed ID

14568126

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14568126

full work available at URL

23 March 2024

https://api.elsevier.com/content/article/PII:S0022510X03001771?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0022-510X(03)00177-1

https://api.elsevier.com/content/article/PII:S0022510X03001771?httpAccept=text/plain

23 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0022-510X(03)00177-1

Journal of the Neurological Sciences

23 March 2024

published in

1 reference

9 February 2018

volume

215

1 reference

9 February 2018

issue

1-2

1 reference

9 February 2018

page(s)

37-44

1 reference

9 February 2018

Glatiramer acetate in the treatment of multiple sclerosis

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900177-1

Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial. The Copolymer 1 Multiple Sclerosis Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900177-1

Treatment of multiple sclerosis with copolymer-1 (Copaxone): implicating mechanisms of Th1 to Th2/Th3 immune-deviation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900177-1

Mechanisms of action of glatiramer acetate in multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900177-1

Mechanisms of immunomodulation by glatiramer acetate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900177-1

Characterization of T cell lines derived from glatiramer-acetate-treated multiple sclerosis patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900177-1

Glatiramer acetate (copolymer-1)-specific, human T cell lines: cytokine profile and suppression of T cell lines reactive against myelin basic protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900177-1

Glatiramer acetate (Copaxone) induces degenerate, Th2-polarized immune responses in patients with multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900177-1

Specific Th2 cells accumulate in the central nervous system of mice protected against experimental autoimmune encephalomyelitis by copolymer 1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900177-1

Mechanisms of action of interferons and glatiramer acetate in multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900177-1

Glatiramer acetate reduces the proportion of new MS lesions evolving into "black holes".

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900177-1

T cell immunity to copolymer 1 confers neuroprotection on the damaged optic nerve: possible therapy for optic neuropathies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900177-1

Vaccination for protection of retinal ganglion cells against death from glutamate cytotoxicity and ocular hypertension: implications for glaucoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900177-1

Dual action of glatiramer acetate (Cop-1) in the treatment of CNS autoimmune and neurodegenerative disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900177-1

Glatiramer acetate-specific T-helper 1- and 2-type cell lines produce BDNF: implications for multiple sclerosis therapy. Brain-derived neurotrophic factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900177-1

BDNF and gp145trkB in multiple sclerosis brain lesions: neuroprotective interactions between immune and neuronal cells?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900177-1

Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900177-1

IFN-beta gene transfer into the central nervous system using bone marrow cells as a delivery system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900177-1

Neurotrophin-3 and brain-derived neurotrophic factor induce oligodendrocyte proliferation and myelination of regenerating axons in the contused adult rat spinal cord.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900177-1

Neurotrophins inhibit major histocompatibility class II inducibility of microglia: involvement of the p75 neurotrophin receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900177-1

Neurotrophins and the anti-inflammatory agents interleukin-4 (IL-4), IL-10, IL-11 and transforming growth factor-beta1 (TGF-beta1) down-regulate T cell costimulatory molecules B7 and CD40 on cultured rat microglia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900177-1

Brain-derived neurotrophic factor rescues spinal motor neurons from axotomy-induced cell death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900177-1

Adenoviral gene transfer of ciliary neurotrophic factor and brain-derived neurotrophic factor leads to long-term survival of axotomized motor neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900177-1

BDNF and NT-4/5 prevent atrophy of rat rubrospinal neurons after cervical axotomy, stimulate GAP-43 and Talpha1-tubulin mRNA expression, and promote axonal regeneration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900177-1

The effects of ciliary neurotrophic factor on motor dysfunction in wobbler mouse motor neuron disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900177-1

Intrastriatal implantation of fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevents degeneration of dopaminergic neurons in a rat model of Parkinson's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900177-1

Brain-derived neurotrophic factor-mediated protection of striatal neurons in an excitotoxic rat model of Huntington's disease, as demonstrated by adenoviral gene transfer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900177-1

7 January 2021

Identifiers

1 reference

9 February 2018

PubMed ID

14568126

1 reference

9 February 2018